What is Inovio Inc?
Inovio Pharmaceuticals Inc, or Inovio for short, was established by David B Weiner on June 29, 1983. It has its headquarters in Plymouth Meeting, PA, and was incorporated in 2001. It is a late-stage biotechnological company that researches and develops synthetic DNA products for treating cancer and infectious diseases. More precisely, Inovio develops immunotherapies and vaccines for treatment and prevention of cancers and infectious diseases (such as HIV and Hepatitis C), anti-inflammatory drugs and animal-related health products.
Inovio’s DNA medicines pipeline consists of the development of multiple human papillomavirus (HPV) and non-HPV targeted medicines. The clinical programmes that focus on developing vaccines and other drugs may be funded from the company's internal sources or by external funders. A specific characteristic of the company is its focus on identifying potential similarities among strings of similar viruses in an effort to create a universal vaccine which is effective against influenza viruses.
Past performance of Inovio share price
Progress on research related to the discovery and production of vaccines and news about the study results along with news and announcements from the FDA may have a significant affect on the Inovio share price. This can also be noticed when looking at the Inovio price chart throughout the past couple of years. For the better part during the past five years, the Inovio share price has been gradually decreasing from approximately $11 (£8.33) down to slightly above $2 (£1.50). However, this multi-year decline was broken with the outbreak of Covid-19.
During the last quarter of 2019, one of the major events that impacted the global financial markets was the coronavirus pandemic which affected stocks in different ways. While many shares experienced a price decrease, the Inovio share price increased and broke the downward trend that lasted for a couple of years. The Inovio price started to form an upward trend with some major peaks and breakouts as well as significant retracements until it reached a high price of around $33 (£25). The upward trend lasted for a couple of months up to the point of hitting a multi-year high when it reversed and started forming a downward trend.
The Inovio stock price may be appealing for traders because it has the potential to move in excess of 30 per cent in only a few days depending on global events. Moreover, this stock may also experience price gaps of more than 10 per cent, which also makes the shares adequate for different trading strategies.
How to invest in Inovio Pharmaceuticals stock
The developments and financial innovations offer a variety of instruments so anyone can invest in Inovio Pharmaceuticals stock or any other stock or investment instrument. However, the availability of multiple diverse options may be a double-edged sword if you decide to invest in Inovio Pharmaceuticals stock with an instrument that doesn't suit your preferences and trading strategy.
Some of the most common methods for trading Inovio shares are the direct purchase from the exchange where it is listed, trading some of the derivative instruments or indirectly through a relevant investment fund. Any of the available options may be used by traders to invest in Inovio Pharmaceuticals stock. However, in an era of financial innovation, traders should open and close positions with an instrument that will bring the most benefit. Hence, the drawbacks of the instruments should be taken into consideration before you decide to trade.
One of the main drawbacks of commonly used instruments is the inclusion of third parties in the transactions which increases the transaction costs and adversely affects the order’s execution time. Also, when more parties are involved in a transaction, the trading process becomes more complex. Recognising this drawback, Currency.com uses technological innovations to tokenise different types of assets and augment the trading experience. More precisely, the platform creates tokenised assets with the application of blockchain technology for the creation of smart contracts. The specific technology utilised by Currency.com enables swift execution of orders and lower costs because it excludes the need for intermediaries and the transaction is executed directly between the platform and the traders.
Moreover, tokenised Inovio Pharmaceuticals shares replicate the changes in shares price, therefore eliminating the need for traders to own the stock directly or enter some form of agreement. In addition, the Currency.com trading platform gives traders the possibility to open positions directly with Bitcoin or Ethereum. Accordingly, by being able to trade with crypto, they avoid potential costs associated with the need to convert cryptocurrencies.
The opportunity to open larger positions where you invest only a portion of the overall position value means that you can boost your gains. This can be better understood by knowing that Currency.com offers a leverage of up to 1:500 on its tokenised shares, whereas the margin for tokenised Inovio Pharmaceuticals shares is only 5 per cent. Simply stated, you can open a position of $15,000 (£11,357) by investing only 5 per cent of the value or $750 (£568). The advantageous aspect is that although traders use only £568 of their money, the profits are calculated based on the overall position value. For instance, a 2 per cent change in price in the right direction can potentially bring $300 (£227), even though you have invested $750.
Tokenised Inovio stock trading guide
Trading tokenised Inovio stock is no more difficult than regular shares. To begin trading tokenised assets, you will need to follow some simple steps:
- Step 1: Register for an account with Currency.com
- Step 2: Deposit funds (with crypto or fiat) in the account
- Step 3: Determine the position size desired, accounting for leverage offered by Currency.com
- Step 4: Determine your trading position (long or short) based on expected share price movement and purchase tokenised INO shares derivatives
- Step 5: Currency.com matches the long orders from its clients with the sell orders and then hedges the unmatched orders through Capital.com, LMAX Digital or exchanges such as Binance, Bitstamp, Kraken, NASDAQ, NYSE and Gain Capital
- Step 6: Close your position when applicable. You can set a take profit or stop loss indicator to ensure you are not required to constantly monitor the price. Funds will deposit back to your account after closing and you can withdraw or take a new position
Why trade tokenised Inovio Pharmaceutical stocks with Currency.com
Inovio Pharmaceutical stock trading at Currency.com tokenised assets exchange has a number of advantages. Tokenised assets are underpinned by robust and immutable blockchain technology. Opening a trade will give you a token that tracks and moves according to the underlying instrument’s price.
- One-stop crypto trading platform
Trade tokenised Inovio Pharmaceutical shares with Bitcoin or Ethereum. Benefit from the stock’s price movements without turning your crypto assets into fiat.
Trade tokenised Inovio Pharmaceutical stocks with a tight market spread, benefit from maker rebates and competitive taker fees.
Experienced traders can trade the world’s top markets, such as Inovio Pharmaceuticals Inc, with up to 1:500 leverage.
- Effective risk management
Manage your risks and secure your profits with stop loss and take profit orders. Save your assets with negative balance protection.
We have a scalable and low latency order management system, which can execute 50 million trades per second.
Currency.com operates under new Belarusian regulation with best-in-class AML and KYC laws.Regulatory details and fees are upfront.